These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
111 related articles for article (PubMed ID: 17240356)
1. Alendronate suppresses tumor angiogenesis by inhibiting Rho activation of endothelial cells. Hashimoto K; Morishige K; Sawada K; Tahara M; Shimizu S; Ogata S; Sakata M; Tasaka K; Kimura T Biochem Biophys Res Commun; 2007 Mar; 354(2):478-84. PubMed ID: 17240356 [TBL] [Abstract][Full Text] [Related]
2. Effects of cloned tumstatin-related and angiogenesis-inhibitory peptides on proliferation and apoptosis of endothelial cells. Zhang GM; Zhang YM; Fu SB; Liu XH; Fu X; Yu Y; Zhang ZY Chin Med J (Engl); 2008 Nov; 121(22):2324-30. PubMed ID: 19080341 [TBL] [Abstract][Full Text] [Related]
3. Alendronate inhibits intraperitoneal dissemination in in vivo ovarian cancer model. Hashimoto K; Morishige K; Sawada K; Tahara M; Kawagishi R; Ikebuchi Y; Sakata M; Tasaka K; Murata Y Cancer Res; 2005 Jan; 65(2):540-5. PubMed ID: 15695397 [TBL] [Abstract][Full Text] [Related]
5. Inhibition of endothelial cell differentiation and proinflammatory cytokine production during angiogenesis by allyl isothiocyanate and phenyl isothiocyanate. Thejass P; Kuttan G Integr Cancer Ther; 2007 Dec; 6(4):389-99. PubMed ID: 18048887 [TBL] [Abstract][Full Text] [Related]
6. Tumor angiogenesis promoted by ex vivo differentiated endothelial progenitor cells is effectively inhibited by an angiogenesis inhibitor, TK1-2. Oh HK; Ha JM; O E; Lee BH; Lee SK; Shim BS; Hong YK; Joe YA Cancer Res; 2007 May; 67(10):4851-9. PubMed ID: 17510415 [TBL] [Abstract][Full Text] [Related]
7. Alendronate inhibits lysophosphatidic acid-induced migration of human ovarian cancer cells by attenuating the activation of rho. Sawada K; Morishige K; Tahara M; Kawagishi R; Ikebuchi Y; Tasaka K; Murata Y Cancer Res; 2002 Nov; 62(21):6015-20. PubMed ID: 12414621 [TBL] [Abstract][Full Text] [Related]
8. Ganoderma tsugae extract inhibits expression of epidermal growth factor receptor and angiogenesis in human epidermoid carcinoma cells: In vitro and in vivo. Hsu SC; Ou CC; Chuang TC; Li JW; Lee YJ; Wang V; Liu JY; Chen CS; Lin SC; Kao MC Cancer Lett; 2009 Aug; 281(1):108-16. PubMed ID: 19332363 [TBL] [Abstract][Full Text] [Related]
9. Fisetin inhibits various attributes of angiogenesis in vitro and in vivo--implications for angioprevention. Bhat TA; Nambiar D; Pal A; Agarwal R; Singh RP Carcinogenesis; 2012 Feb; 33(2):385-93. PubMed ID: 22139440 [TBL] [Abstract][Full Text] [Related]
10. Anti-tumor actions of major component 3'-O-acetylhamaudol of Angelica japonica roots through dual actions, anti-angiogenesis and intestinal intraepithelial lymphocyte activation. Kimura Y; Sumiyoshi M; Baba K Cancer Lett; 2008 Jun; 265(1):84-97. PubMed ID: 18358599 [TBL] [Abstract][Full Text] [Related]
11. [Inhibitory effect of tetrandrine on angiogenesis]. Qian XP; Liu BR; Hu J; Li M; Hu WJ; Sun J; Yu LX Ai Zheng; 2008 Oct; 27(10):1050-5. PubMed ID: 18851784 [TBL] [Abstract][Full Text] [Related]
12. mTOR inhibitor RAD001 (everolimus) has antiangiogenic/vascular properties distinct from a VEGFR tyrosine kinase inhibitor. Lane HA; Wood JM; McSheehy PM; Allegrini PR; Boulay A; Brueggen J; Littlewood-Evans A; Maira SM; Martiny-Baron G; Schnell CR; Sini P; O'Reilly T Clin Cancer Res; 2009 Mar; 15(5):1612-22. PubMed ID: 19223496 [TBL] [Abstract][Full Text] [Related]
14. Antiangiogenic effect of ZSTK474, a novel phosphatidylinositol 3-kinase inhibitor. Kong D; Okamura M; Yoshimi H; Yamori T Eur J Cancer; 2009 Mar; 45(5):857-65. PubMed ID: 19144509 [TBL] [Abstract][Full Text] [Related]
15. Tumor anti-angiogenic effect and mechanism of action of delta-tocotrienol. Shibata A; Nakagawa K; Sookwong P; Tsuzuki T; Oikawa S; Miyazawa T Biochem Pharmacol; 2008 Aug; 76(3):330-9. PubMed ID: 18599020 [TBL] [Abstract][Full Text] [Related]
16. Antiangiogenic activity of ursolic acid. Kanjoormana M; Kuttan G Integr Cancer Ther; 2010 Jun; 9(2):224-35. PubMed ID: 20462855 [TBL] [Abstract][Full Text] [Related]
17. Activation of fractalkine/CX3CR1 by vascular endothelial cells induces angiogenesis through VEGF-A/KDR and reverses hindlimb ischaemia. Ryu J; Lee CW; Hong KH; Shin JA; Lim SH; Park CS; Shim J; Nam KB; Choi KJ; Kim YH; Han KH Cardiovasc Res; 2008 May; 78(2):333-40. PubMed ID: 18006432 [TBL] [Abstract][Full Text] [Related]
18. Effect of Src kinase inhibition on metastasis and tumor angiogenesis in human pancreatic cancer. Ischenko I; Guba M; Yezhelyev M; Papyan A; Schmid G; Green T; Fennell M; Jauch KW; Bruns CJ Angiogenesis; 2007; 10(3):167-82. PubMed ID: 17486419 [TBL] [Abstract][Full Text] [Related]
19. ACTIBIND, an actin-binding fungal T2-RNase with antiangiogenic and anticarcinogenic characteristics. Roiz L; Smirnoff P; Bar-Eli M; Schwartz B; Shoseyov O Cancer; 2006 May; 106(10):2295-308. PubMed ID: 16586499 [TBL] [Abstract][Full Text] [Related]
20. [Inhibitory effects of Scutellaria barbatae D. Don on tumor angiogenesis and its mechanism]. Zhang NN; Bu P; Zhu HH; Shen WG Ai Zheng; 2005 Dec; 24(12):1459-63. PubMed ID: 16351792 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]